Editorial
World J Exp Med
3(4):50-55.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.50
Abstract (1285)
|
Core Tip (1178)
|
Full Article (HTML) (3981)
|
Figures (1-1) (80)
|
Full Article (PDF)-1868K (471)
|
Peer-Review Report-76K (258)
|
Answering Reviewers-79K (324)
|
Received: 06/28/2013
|
Revised: 09/06/2013
|
Accepted: 11/08/2013
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (10140)
|
Similar Articles (281)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Exp Med
3(4):56-61.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.56
Abstract (1366)
|
Core Tip (1389)
|
Full Article (HTML) (7108)
|
Figures (1-1) (88)
|
Tables (1-1) (79)
|
Full Article (PDF)-2122K (637)
|
Peer-Review Report-138K (330)
|
Answering Reviewers-378K (375)
|
Received: 06/28/2013
|
Revised: 09/16/2013
|
Accepted: 11/03/2013
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (13882)
|
Similar Articles (196)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
World J Exp Med
3(4):62-73.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.62
Abstract (968)
|
Core Tip (904)
|
Full Article (HTML) (3087)
|
Full Article (PDF)-2198K (304)
|
Peer-Review Report-77K (188)
|
Answering Reviewers-70K (144)
|
Received: 07/30/2013
|
Revised: 09/27/2013
|
Accepted: 11/05/2013
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7659)
|
Similar Articles (21)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Exp Med
3(4):74-86.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.74
Abstract (1493)
|
Core Tip (1356)
|
Full Article (HTML) (6277)
|
Figures (1-1) (87)
|
Full Article (PDF)-3670K (511)
|
Peer-Review Report-107K (250)
|
Answering Reviewers-72K (186)
|
Received: 06/28/2013
|
Revised: 09/06/2013
|
Accepted: 11/03/2013
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (12335)
|
Similar Articles (3)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Exp Med
3(4):87-99.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.87
Abstract (1189)
|
Core Tip (1051)
|
Full Article (HTML) (4226)
|
Figures (1-2) (74)
|
Tables (1-2) (71)
|
Full Article (PDF)-4074K (467)
|
Peer-Review Report-85K (215)
|
Answering Reviewers-352K (185)
|
Received: 05/29/2013
|
Accepted: 10/16/2013
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (8948)
|
Similar Articles (0)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Original Article
Epigallocatechin-3-gallate suppresses transforming growth factor-beta signaling by interacting with the transforming growth factor-beta type II receptor
World J Exp Med
3(4):100-107.
Published online Nov 20, 2013.
doi: 10.5493/wjem.v3.i4.100
Abstract (1672)
|
Core Tip (1240)
|
Full Article (HTML) (5619)
|
Figures (1-5) (116)
|
Full Article (PDF)-1926K (444)
|
Peer-Review Report-206K (283)
|
Answering Reviewers-219K (369)
|
Received: 05/14/2013
|
Revised: 07/12/2013
|
Accepted: 09/18/2013
|
CrossRef
|
Google Scholar
|
Times Cited (7)
|
Total Visits (11977)
|
Similar Articles (4)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open